Featured Editorial

  1. The End Of Just-In-Time? Why Clinical Trial Supply Chains Are Rethinking Inventory Strategy 9/9/2026

    Clinical trials are too unpredictable for inventory strategies built on fixed assumptions. Learn why agility, visibility and smarter buffers are becoming essential to supply planning.

  2. Root Causes, Part 1: When Trial Design Locks In Supply Risk 9/8/2026

    This first installment of our new Root Causes video series examines how decisions made long before execution can shape clinical supply outcomes.

  3. Last-Mile Lessons For Depot-To-Site Delivery 9/7/2026

    Depot-to-site delivery is more than a courier handoff. See how reconciliation gaps, temperature risks, and mismatched SLAs can turn last-mile issues into trial delays.

  4. Expanded Expertise, Deeper Insight: Clinical Supply Leader Welcomes Two New Advisors 9/4/2026

    Clinical Supply Leader expands its Editorial Advisory Board expertise with the addition of Éamonn McArdle (Allergy Therapeutics) and Juan Hernandez (Bensen Solutions).

  5. The Hidden Cost Of The "Cheap" Comparator Drug: Why The Lowest Price Can Become The Most Expensive Choice In Clinical Trials 9/4/2026

    The cheapest comparator can become the costliest choice. See how shelf life, logistics, quality, wastage and supply continuity can turn apparent savings into trial risk.

  6. Could Smarter Use of Clinical Supply Data Help Avoid Certain Protocol Amendments? 9/3/2026

    Clinical supply data reveals where protocol assumptions break down. Could those lessons help improve protocol design and reduce avoidable amendments?

  7. The Silent Threat To Clinical Trials: Why Shelf-Life Management Can Determine Study Success 9/3/2026

    Shelf life is more than an expiration date. Explore how global trials can turn aging inventory into supply disruptions, added costs, and risks to patient treatment.

  8. CDMO Quality Oversight: How FDA And Pharma Leaders Are Rethinking Data, AI, And Culture 9/2/2026

    Discover strategies for risk-based governance, AI-enabled quality management, stronger collaboration, and fostering a culture that supports long-term operational excellence.

  9. AI Is Only As Good As The Data Behind Your Clinical Trial Supply Chain 9/2/2026

    AI cannot fix bad clinical supply data. Disconnected systems, conflicting inventory and manual workarounds can turn smart forecasting into costly mistakes.

  10. Five Places Where AI Stalls In Clinical Supply 9/1/2026

    AI may be ready for clinical supply, but the systems behind it are not. Five barriers show why better models alone will not fix forecasting or waste.